Therapy of allergic pulmonary diseases with anti-IgE antibodies. A review

被引:0
|
作者
Fick, RB [1 ]
机构
[1] Genentech Inc, S San Francisco, CA 94080 USA
关键词
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
引用
收藏
页码:115 / 117
页数:3
相关论文
共 50 条
  • [31] Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis
    Jat, Kana R.
    Walia, Dinesh K.
    Khairwa, Anju
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (09):
  • [32] Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis
    Jat, Kana R.
    Walia, Dinesh K.
    Khairwa, Anju
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (03):
  • [33] Recombinant human monoclonal anti-IgE therapy in allergic rhinitis.
    Casale, TB
    Bernstein, IL
    Busse, WW
    LaForce, CF
    Tinkelman, DG
    Stoltz, RR
    Dockhorn, RJ
    Adelman, DC
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1996, 97 (01) : 67 - 67
  • [34] Anti-IgE therapy for asthma
    Demoly, P
    Bousquet, J
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 155 (06) : 1825 - 1827
  • [35] ANTI-IGE ANTIBODIES IN HYPOSENSITIZED PATIENTS
    LOIDOLT, D
    VASSELLA, CC
    DEWECK, AL
    STADLER, BM
    LARYNGO-RHINO-OTOLOGIE, 1990, 69 (05) : 255 - 259
  • [36] Can anti-IgE therapy prevent airway remodeling in allergic asthma?
    Rabe, K. F.
    Calhoun, W. J.
    Smith, N.
    Jimenez, P.
    ALLERGY, 2011, 66 (09) : 1142 - 1151
  • [37] Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis
    Jat, Kana R.
    Walia, Dinesh K.
    Khairwa, Anju
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (09):
  • [38] CONTAMINATING ANTIBODIES IN ANTI-IGE ANTISERA
    BERNIER, GM
    MCINTYRE, OR
    JOURNAL OF IMMUNOLOGICAL METHODS, 1976, 13 (01) : 91 - 95
  • [39] Anti-IgE antibodies for the treatment of asthma
    Buhl, R
    CURRENT OPINION IN PULMONARY MEDICINE, 2005, 11 (01) : 27 - 34
  • [40] Therapy of allergic bronchial asthma with omalizumab - an anti-IgE monoclonal antibody
    D'Amato, G
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2003, 3 (02) : 371 - 376